Studies have shown that both serum CD137 concentrations and tumor infiltration by M1 macrophages can be used as potential predictive biomarkers, with both high serum CD137 concentrations and high-density M1 macrophage infiltration in the tumor stroma significantly associated with better outcomes, prolonged PFS and OS (59). Here, TNFRSF9 is linked to neoplasm.